Top Markets
Coin of the day
Longboard Pharmaceuticals, Inc. Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc.

LBPH
Kedudukan dalam Saham #8563
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm committed to advancing innovative treatments for neurological conditions. Its primary drug candidate, LP352, is currently progressing through a Phase 1b/2a clinical trial, aimed at managing seizures associated with developmental and epileptic encephalopathies. The company also boasts preclinical pipeline candidates, LP659 and LP143, designed to tackle a range of neurological diseases. Incorporated in 2020, the company, formerly known as Arena Neuroscience, Inc., adopted its current name, Longboard Pharmaceuticals, Inc., in October 2020. Its corporate headquarters are situated in La Jolla, California.
Harga Saham
$59.98
Disegerakkan terakhir: 2024-12-13
Modal Pasaran
$1.22B
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Longboard Pharmaceuticals, Inc. (LBPH)

Kategori

EPS untuk Longboard Pharmaceuticals, Inc. (LBPH)
EPS setakat September 2024 TTM: $-2.24
Menurut laporan kewangan terkini dan harga saham Longboard Pharmaceuticals, Inc., EPS semasa syarikat (TTM) adalah $-2.24. Pada akhir tahun 2022, syarikat mempunyai EPS sebanyak $-2.51 peningkatan berbanding EPS tahun 2021 iaitu $-1.62.
Sejarah EPS untuk Longboard Pharmaceuticals, Inc. dari 2020 hingga 2026
EPS pada akhir setiap tahun
Tahun EPS Ubah
2026 (TTM) $-2.24 -6.28%
2023 $-2.39 -4.78%
2022 $-2.51 54.94%
2021 $-1.62 97.56%
2020 $-0.82 0.00%
EPS untuk syarikat atau pesaing yang serupa
Syarikat EPS Perbezaan EPS Negara
$17.32 -873.21%
US
$27.74 -1,338.39%
NL
$-5.29 136.16%
AU
$-7.98 256.25%
US
- -
CH